Detection of circulating tumor cells (CTCs) in the blood of cancer patients is of intense interest to medical oncologists. The promise of being able to detect such rare cells consistently and reproducibly has attracted considerable ...
Dec 9, 2021
0
1
New findings from a landmark study indicate there may be a way to predict treatment response in breast cancer patients even before treatment begins. The study results led by Susan G. Komen Brinker Award winner Carlos Caldas, ...
Dec 8, 2021
0
63
A type of cell transformation known as EMT enables cancer cells to break away from the tumor and form metastases elsewhere. However, this process does not always take place in full. Researchers at the University of Basel ...
Nov 29, 2021
0
79
A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state in which they are unable to proliferate. The study, published November 23 in the Journal of Experimental ...
Nov 23, 2021
0
42
Researchers have identified a metabolic enzyme and pathway in some triple-negative breast cancer (TNBC) patients, which they hope could serve as a biomarker to select patients to receive targeted therapy.
Nov 16, 2021
0
55
Breast cancers that have an overactive PI3K enzyme, involved in cell growth and division, tend to be more aggressive and to spread and divide more like stem cells. But a new study by Ralitsa Madsen of University College London ...
Nov 11, 2021
0
19
George Washington University researchers have identified a key molecule in certain kinds of breast cancers that prevent immune cells from entering tumors and killing the cancer cells inside. The paper and its findings, published ...
Nov 3, 2021
0
191
A new study adds to the evidence that chemotherapy enhances cancer's spread beyond the primary tumor, showing how one chemo drug allows breast cancer cells to squeeze through and attach to blood vessel linings in the lungs.
Nov 2, 2021
0
1334
Immunotherapy using checkpoint inhibitors can work well to treat cancer, but only a minority of patients respond to therapy. Researchers at the University of Alabama at Birmingham have now shown—in preclinical experiments—how ...
Oct 28, 2021
0
31
A multi-institution team of researchers led by scientists at Baylor College of Medicine has discovered a genetic signature that can identify drivers of poor outcomes in advanced estrogen-receptor positive (ER+) breast cancer, ...
Oct 28, 2021
0
55
